Cancers | Free Full-Text | Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-Analysis
Faculty | CoBrCa – Controversies in Breast Cancer
Transnational cancer research lab | Felsenstein Medical Research Center
Transnational cancer research lab | Felsenstein Medical Research Center
Salomon Stemmer - Advisory board @ DocBox - Crunchbase Person Profile
מחקר תרגומי בסרטן
Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer
PDF) The Effectiveness of Group Intervention on Enhancing Cognitive Emotion Regulation Strategies in Breast Cancer Patients: A 2-Year Follow-up | Ruth Pat-Horenczyk, Salomon Stemmer, Shlomit Perry, and Yaira Hamama-raz - Academia.edu
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
First-of-its-kind study in Israel finds that cancer patients are safe for COVID-19 vaccines - EJP
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
OncologyEducation a Twitter: "Dr. Salomon Stemmer provides an update of Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this video from #ASCO19: https://t.co/82i6FiWc4l https://t.co/SlkSpAAMot" / Twitter
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy | Cancer Discovery
Cetuximab intensifies cisplatin-induced testicular toxicity - ppt download
Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients | Business Wire
Ajay Singh - Cofounder & CPTO - speechx | LinkedIn
Cancer Patients Develop 'Adequate' Immune Response to COVID Vax | MedPage Today
Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study | SpringerLink
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry – ScienceOpen
![Treating HER2-mutant advanced biliary tract cancer with ... Treating HER2-mutant advanced biliary tract - [PDF Document]](https://static.fdocuments.in/img/1200x630/reader022/reader/2020062715/5edc095ead6a402d666687a4/r-1.jpg?t=1632260937 "Treating HER2-mutant advanced biliary tract cancer with ... Treating HER2-mutant advanced biliary tract - [PDF Document]")
Treating HER2-mutant advanced biliary tract cancer with ... Treating HER2-mutant advanced biliary tract - [PDF Document]
UT Southwestern Radiation Oncology - Congratulations to Dr. Prasanna Alluri, Assistant Professor of Radiation Oncology at UT Southwestern, and Dr. Salomon Stemmer, Professor in Oncology at Rabin Medical Center, for being awarded
COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs | The Times of Israel
Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
